Literature DB >> 30146614

Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action.

Manabu Nagao1, Hideto Nakajima1, Ryuji Toh2, Ken-Ichi Hirata1, Tatsuro Ishida1.   

Abstract

High-density lipoprotein cholesterol (HDL-C) has been identified as a powerful independent negative predictor of cardiovascular disease. The beneficial effect of HDL is largely attributable to its key role in reverse cholesterol transport, whereby excess cholesterol in the peripheral tissues is transported to the liver, reducing the atherosclerotic burden. However, mounting evidence indicates that HDL also has pleiotropic properties, such as anti-inflammatory, anti-oxidative, and vasodilatory properties, which may contribute in reducing the incidence of heart failure. Actually, previous data from clinical and experimental studies have suggested that HDL exerts cardioprotective effects irrespective of the presence/absence of coronary artery disease. This review summarizes the currently available evidence regarding beneficial effects of HDL on the heart beyond its anti-atherogenic property. Understanding the mechanisms of cardiac protection by HDL will provide new insight into the underlying mechanism and therapeutic strategy for heart failure.

Entities:  

Keywords:  Cardioprotective effect; Endothelial lipase; Fatty acid; Heart failure; High-density lipoprotein; mTOR signal

Mesh:

Substances:

Year:  2018        PMID: 30146614      PMCID: PMC6193192          DOI: 10.5551/jat.RV17025

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  79 in total

Review 1.  The PPARs: from orphan receptors to drug discovery.

Authors:  T M Willson; P J Brown; D D Sternbach; B R Henke
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

2.  High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.

Authors:  Waleed Ahmed; Gabriela Orasanu; Vedika Nehra; Liana Asatryan; Daniel J Rader; Ouliana Ziouzenkova; Jorge Plutzky
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

3.  Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

Authors:  J Niebauer; H D Volk; M Kemp; M Dominguez; R R Schumann; M Rauchhaus; P A Poole-Wilson; A J Coats; S D Anker
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

4.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

5.  Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.

Authors:  Kalyani G Bharadwaj; Yaeko Hiyama; Yunying Hu; Lesley Ann Huggins; Rajasekhar Ramakrishnan; Nada A Abumrad; Gerald I Shulman; William S Blaner; Ira J Goldberg
Journal:  J Biol Chem       Date:  2010-09-18       Impact factor: 5.157

6.  Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

7.  Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia.

Authors:  Nobuaki Tanaka; Tatsuro Ishida; Manabu Nagao; Takeshige Mori; Tomoko Monguchi; Maki Sasaki; Kenta Mori; Kensuke Kondo; Hideto Nakajima; Tomoyuki Honjo; Yasuhiro Irino; Ryuji Toh; Masakazu Shinohara; Ken-ichi Hirata
Journal:  Atherosclerosis       Date:  2014-10-18       Impact factor: 5.162

Review 8.  Role of inflammation in the progression of heart failure.

Authors:  Arne Yndestad; Jan Kristian Damås; Erik Øie; Thor Ueland; Lars Gullestad; Pål Aukrust
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

9.  Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity.

Authors:  S Takahashi; Y Kawarabayasi; T Nakai; J Sakai; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy.

Authors:  Pankaj Shende; Lifen Xu; Christian Morandi; Laura Pentassuglia; Philippe Heim; Sonia Lebboukh; Corinne Berthonneche; Thierry Pedrazzini; Beat A Kaufmann; Michael N Hall; Markus A Rüegg; Marijke Brink
Journal:  Cardiovasc Res       Date:  2015-11-23       Impact factor: 10.787

View more
  9 in total

Review 1.  HDL as Bidirectional Lipid Vectors: Time for New Paradigms.

Authors:  María Luna-Luna; Eric Niesor; Óscar Pérez-Méndez
Journal:  Biomedicines       Date:  2022-05-20

2.  Fibronectin-containing High-Density Lipoprotein is Associated with Cancer Cell Adhesion and Proliferation.

Authors:  Eriko Hisamatsu; Manabu Nagao; Ryuji Toh; Yasuhiro Irino; Takuya Iino; Tetsuya Hara; Hidekazu Tanaka; Seimi Satomi-Kobayashi; Tatsuro Ishida; Ken-Ichi Hirata
Journal:  Kobe J Med Sci       Date:  2020-08-17

3.  Evaluation of monocyte-to-high-density lipoprotein cholesterol ratio and monocyte-to-lymphocyte ratio in ischemic stroke.

Authors:  Huiling Liu; Feng Zhan; Yazhou Wang
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

4.  Effects of Living High-Training Low and High on Body Composition and Metabolic Risk Markers in Overweight and Obese Females.

Authors:  Huan Gao; Jianfang Xu; Li Zhang; Yingli Lu; Binghong Gao; Lianshi Feng
Journal:  Biomed Res Int       Date:  2020-02-11       Impact factor: 3.411

5.  Adjustment of the GRACE Risk Score by Monocyte to High-Density Lipoprotein Ratio Improves Prediction of Adverse Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Xiaoteng Ma; Kangning Han; Lixia Yang; Qiaoyu Shao; Qiuxuan Li; Zhijian Wang; Yueping Li; Fei Gao; Zhiqiang Yang; Dongmei Shi; Yujie Zhou
Journal:  Front Cardiovasc Med       Date:  2022-01-26

Review 6.  HDL Receptor in Schistosoma japonicum Mediating Egg Embryonation: Potential Molecular Basis for High Prevalence of Cholesteryl Ester Transfer Protein Deficiency in East Asia.

Authors:  Shinji Yokoyama
Journal:  Front Cell Dev Biol       Date:  2022-03-17

7.  Protective cardiovascular benefits of exercise training as measured by circulating endothelial cells and high-density lipoprotein in adults.

Authors:  Kumboyono Kumboyono; Indah N Chomsy; Dylan H Firdaus; Meddy Setiawan; Titin A Wihastuti
Journal:  J Taibah Univ Med Sci       Date:  2022-01-23

Review 8.  HDL and type 2 diabetes: the chicken or the egg?

Authors:  Eva Xepapadaki; Ioanna Nikdima; Eleftheria C Sagiadinou; Evangelia Zvintzou; Kyriakos E Kypreos
Journal:  Diabetologia       Date:  2021-07-13       Impact factor: 10.122

9.  HDL functions and their interaction in patients with ST elevation myocardial infarction: a case control study.

Authors:  Himani Thakkar; Vinnyfred Vincent; Ambuj Roy; Sandeep Singh; Lakshmy Ramakrishnan; Mani Kalaivani; Archna Singh
Journal:  Lipids Health Dis       Date:  2020-04-15       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.